-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
-
(2010)
Int. J. Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
23044488917
-
Report of the 16th follow-up survey of primary liver cancer
-
I. Ikai, S. Arii, T. Ichida, K. Okita, M. Omata, M. Kojiro, K. Takayasu, Y. Nakanuma, M. Makuuchi, Y. Matsuyama, and Y. Yamaoka Report of the 16th follow-up survey of primary liver cancer Hepatol. Res. 32 2005 163 172
-
(2005)
Hepatol. Res.
, vol.32
, pp. 163-172
-
-
Ikai, I.1
Arii, S.2
Ichida, T.3
Okita, K.4
Omata, M.5
Kojiro, M.6
Takayasu, K.7
Nakanuma, Y.8
Makuuchi, M.9
Matsuyama, Y.10
Yamaoka, Y.11
-
3
-
-
0035467993
-
Global cancer statistics in the year 2000
-
D.M. Parkin Global cancer statistics in the year 2000 Lancet Oncol. 2 2001 533 543
-
(2001)
Lancet Oncol.
, vol.2
, pp. 533-543
-
-
Parkin, D.M.1
-
4
-
-
0033545541
-
Rising incidence of hepatocellular carcinoma in the United States
-
H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N. Engl. J. Med. 340 1999 745 750
-
(1999)
N. Engl. J. Med.
, vol.340
, pp. 745-750
-
-
El-Serag, H.B.1
Mason, A.C.2
-
5
-
-
0042967416
-
Time trends in cancer mortality in China: 1987-1999
-
L. Yang, D.M. Parkin, L. Li, and Y. Chen Time trends in cancer mortality in China: 1987-1999 Int. J. Cancer 106 2003 771 783
-
(2003)
Int. J. Cancer
, vol.106
, pp. 771-783
-
-
Yang, L.1
Parkin, D.M.2
Li, L.3
Chen, Y.4
-
6
-
-
0037530573
-
Recurrence and metastasis of hepatocellular carcinoma: Progress and prospects
-
X.D. Zhou Recurrence and metastasis of hepatocellular carcinoma: progress and prospects Hepatobiliary Pancreat. Dis. Int. 1 2002 35 41
-
(2002)
Hepatobiliary Pancreat. Dis. Int.
, vol.1
, pp. 35-41
-
-
Zhou, X.D.1
-
7
-
-
17344372847
-
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma
-
Y. Ito, Y. Sasaki, M. Horimoto, S. Wada, Y. Tanaka, A. Kasahara, T. Ueki, T. Hirano, H. Yamamoto, J. Fujimoto, E. Okamoto, N. Hayashi, and M. Hori Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma Hepatology 27 1998 951 958
-
(1998)
Hepatology
, vol.27
, pp. 951-958
-
-
Ito, Y.1
Sasaki, Y.2
Horimoto, M.3
Wada, S.4
Tanaka, Y.5
Kasahara, A.6
Ueki, T.7
Hirano, T.8
Yamamoto, H.9
Fujimoto, J.10
Okamoto, E.11
Hayashi, N.12
Hori, M.13
-
8
-
-
16644390138
-
Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma
-
Y. Tsuboi, T. Ichida, S. Sugitani, T. Genda, J. Inayoshi, M. Takamura, Y. Matsuda, M. Nomoto, and Y. Aoyagi Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma Liver Int. 24 2004 432 436
-
(2004)
Liver Int.
, vol.24
, pp. 432-436
-
-
Tsuboi, Y.1
Ichida, T.2
Sugitani, S.3
Genda, T.4
Inayoshi, J.5
Takamura, M.6
Matsuda, Y.7
Nomoto, M.8
Aoyagi, Y.9
-
9
-
-
36549013178
-
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection
-
K.J. Schmitz, J. Wohlschlaeger, H. Lang, G.C. Sotiropoulos, M. Malago, K. Steveling, H. Reis, V.R. Cicinnati, K.W. Schmid, and H.A. Baba Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection J. Hepatol. 48 2008 83 90
-
(2008)
J. Hepatol.
, vol.48
, pp. 83-90
-
-
Schmitz, K.J.1
Wohlschlaeger, J.2
Lang, H.3
Sotiropoulos, G.C.4
Malago, M.5
Steveling, K.6
Reis, H.7
Cicinnati, V.R.8
Schmid, K.W.9
Baba, H.A.10
-
10
-
-
0021751250
-
Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain
-
I. Bernier, and P. Jolles Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain Biochim. Biophys. Acta 790 1984 174 181
-
(1984)
Biochim. Biophys. Acta
, vol.790
, pp. 174-181
-
-
Bernier, I.1
Jolles, P.2
-
11
-
-
0029123401
-
From structure to function: Possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site
-
F. Schoentgen, and P. Jolles From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding site FEBS Lett. 369 1995 22 26
-
(1995)
FEBS Lett.
, vol.369
, pp. 22-26
-
-
Schoentgen, F.1
Jolles, P.2
-
12
-
-
0033539167
-
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
-
K. Yeung, T. Seitz, S. Li, P. Janosch, B. McFerran, C. Kaiser, F. Fee, K.D. Katsanakis, D.W. Rose, H. Mischak, J.M. Sedivy, and W. Kolch Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP Nature 401 1999 173 177
-
(1999)
Nature
, vol.401
, pp. 173-177
-
-
Yeung, K.1
Seitz, T.2
Li, S.3
Janosch, P.4
McFerran, B.5
Kaiser, C.6
Fee, F.7
Katsanakis, K.D.8
Rose, D.W.9
Mischak, H.10
Sedivy, J.M.11
Kolch, W.12
-
13
-
-
3442883359
-
Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines
-
M.M. Schuierer, F. Bataille, S. Hagan, W. Kolch, and A.K. Bosserhoff Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines Cancer Res. 64 2004 5186 5192
-
(2004)
Cancer Res.
, vol.64
, pp. 5186-5192
-
-
Schuierer, M.M.1
Bataille, F.2
Hagan, S.3
Kolch, W.4
Bosserhoff, A.K.5
-
14
-
-
27144473329
-
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis
-
S. Hagan, F. Al-Mulla, E. Mallon, K. Oien, R. Ferrier, B. Gusterson, J.J. Garcia, and W. Kolch Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis Clin. Cancer Res. 11 2005 7392 7397
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 7392-7397
-
-
Hagan, S.1
Al-Mulla, F.2
Mallon, E.3
Oien, K.4
Ferrier, R.5
Gusterson, B.6
Garcia, J.J.7
Kolch, W.8
-
15
-
-
33749161559
-
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma
-
M.M. Schuierer, F. Bataille, T.S. Weiss, C. Hellerbrand, and A.K. Bosserhoff Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma Oncol. Rep. 16 2006 451 456
-
(2006)
Oncol. Rep.
, vol.16
, pp. 451-456
-
-
Schuierer, M.M.1
Bataille, F.2
Weiss, T.S.3
Hellerbrand, C.4
Bosserhoff, A.K.5
-
16
-
-
33749319933
-
Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells
-
H.C. Lee, B. Tian, J.M. Sedivy, J.R. Wands, and M. Kim Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells Gastroenterology 131 2006 1208 1217
-
(2006)
Gastroenterology
, vol.131
, pp. 1208-1217
-
-
Lee, H.C.1
Tian, B.2
Sedivy, J.M.3
Wands, J.R.4
Kim, M.5
-
17
-
-
85047699198
-
Nuclear transcription factor-kappaB as a target for cancer drug development
-
A. Garg, and B.B. Aggarwal Nuclear transcription factor-kappaB as a target for cancer drug development Leukemia 16 2002 1053 1068
-
(2002)
Leukemia
, vol.16
, pp. 1053-1068
-
-
Garg, A.1
Aggarwal, B.B.2
-
18
-
-
4644324186
-
NF-kappaB functions as a tumour promoter in inflammation-associated cancer
-
E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
-
(2004)
Nature
, vol.431
, pp. 461-466
-
-
Pikarsky, E.1
Porat, R.M.2
Stein, I.3
Abramovitch, R.4
Amit, S.5
Kasem, S.6
Gutkovich-Pyest, E.7
Urieli-Shoval, S.8
Galun, E.9
Ben-Neriah, Y.10
-
19
-
-
33645457576
-
Constitutive activation of NF-kappaB in human hepatocellular carcinoma: Evidence of a cytoprotective role
-
L. Qiao, H. Zhang, J. Yu, R. Francisco, P. Dent, M.P. Ebert, C. Rocken, and G. Farrell Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role Hum. Gene Ther. 17 2006 280 290
-
(2006)
Hum. Gene Ther.
, vol.17
, pp. 280-290
-
-
Qiao, L.1
Zhang, H.2
Yu, J.3
Francisco, R.4
Dent, P.5
Ebert, M.P.6
Rocken, C.7
Farrell, G.8
-
20
-
-
0034791116
-
Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation
-
K.C. Yeung, D.W. Rose, A.S. Dhillon, D. Yaros, M. Gustafsson, D. Chatterjee, B. McFerran, J. Wyche, W. Kolch, and J.M. Sedivy Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation Mol. Cell. Biol. 21 2001 7207 7217
-
(2001)
Mol. Cell. Biol.
, vol.21
, pp. 7207-7217
-
-
Yeung, K.C.1
Rose, D.W.2
Dhillon, A.S.3
Yaros, D.4
Gustafsson, M.5
Chatterjee, D.6
McFerran, B.7
Wyche, J.8
Kolch, W.9
Sedivy, J.M.10
-
21
-
-
77649272556
-
RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex
-
H. Tang, S. Park, S.C. Sun, R. Trumbly, G. Ren, E. Tsung, and K.C. Yeung RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex FEBS Lett. 584 2010 662 668
-
(2010)
FEBS Lett.
, vol.584
, pp. 662-668
-
-
Tang, H.1
Park, S.2
Sun, S.C.3
Trumbly, R.4
Ren, G.5
Tsung, E.6
Yeung, K.C.7
-
22
-
-
49549110516
-
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer
-
K.M. Woods Ignatoski, N.K. Grewal, S.M. Markwart, A. Vellaichamy, A.M. Chinnaiyan, K. Yeung, M.E. Ray, and E.T. Keller Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 72 2008 153 160
-
(2008)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.72
, pp. 153-160
-
-
Woods Ignatoski, K.M.1
Grewal, N.K.2
Markwart, S.M.3
Vellaichamy, A.4
Chinnaiyan, A.M.5
Yeung, K.6
Ray, M.E.7
Keller, E.T.8
-
23
-
-
39049089692
-
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion
-
K.T. Mc Henry, R. Montesano, S. Zhu, A.B. Beshir, H.H. Tang, K.C. Yeung, and G. Fenteany Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion J. Cell. Biochem. 103 2008 972 985
-
(2008)
J. Cell. Biochem.
, vol.103
, pp. 972-985
-
-
Mc Henry, K.T.1
Montesano, R.2
Zhu, S.3
Beshir, A.B.4
Tang, H.H.5
Yeung, K.C.6
Fenteany, G.7
-
24
-
-
34249709470
-
Loss of Raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer
-
P. Minoo, I. Zlobec, K. Baker, L. Tornillo, L. Terracciano, J.R. Jass, and A. Lugli Loss of Raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer Am. J. Clin. Pathol. 127 2007 820 827
-
(2007)
Am. J. Clin. Pathol.
, vol.127
, pp. 820-827
-
-
Minoo, P.1
Zlobec, I.2
Baker, K.3
Tornillo, L.4
Terracciano, L.5
Jass, J.R.6
Lugli, A.7
-
25
-
-
19944410494
-
RKIP downregulates B-Raf kinase activity in melanoma cancer cells
-
S. Park, M.L. Yeung, S. Beach, J.M. Shields, and K.C. Yeung RKIP downregulates B-Raf kinase activity in melanoma cancer cells Oncogene 24 2005 3535 3540
-
(2005)
Oncogene
, vol.24
, pp. 3535-3540
-
-
Park, S.1
Yeung, M.L.2
Beach, S.3
Shields, J.M.4
Yeung, K.C.5
-
26
-
-
0038275924
-
Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis
-
Z. Fu, P.C. Smith, L. Zhang, M.A. Rubin, R.L. Dunn, Z. Yao, and E.T. Keller Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis J. Natl. Cancer Inst. 95 2003 878 889
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 878-889
-
-
Fu, Z.1
Smith, P.C.2
Zhang, L.3
Rubin, M.A.4
Dunn, R.L.5
Yao, Z.6
Keller, E.T.7
-
27
-
-
2342435822
-
RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis
-
D. Chatterjee, Y. Bai, Z. Wang, S. Beach, S. Mott, R. Roy, C. Braastad, Y. Sun, A. Mukhopadhyay, B.B. Aggarwal, J. Darnowski, P. Pantazis, J. Wyche, Z. Fu, Y. Kitagwa, E.T. Keller, J.M. Sedivy, and K.C. Yeung RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis J. Biol. Chem. 279 2004 17515 17523
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 17515-17523
-
-
Chatterjee, D.1
Bai, Y.2
Wang, Z.3
Beach, S.4
Mott, S.5
Roy, R.6
Braastad, C.7
Sun, Y.8
Mukhopadhyay, A.9
Aggarwal, B.B.10
Darnowski, J.11
Pantazis, P.12
Wyche, J.13
Fu, Z.14
Kitagwa, Y.15
Keller, E.T.16
Sedivy, J.M.17
Yeung, K.C.18
|